Things
The project aims to ensure that Italy and the European Union create industrial and technological skills and capabilities such as to strengthen their strategic autonomy in research and production and competitiveness on the international scene.
Who is it aimed at?
To companies and research organizations interested in participating in the construction of projects that must correspond to one or more of the following objectives:• Prevention and fight against health crises and the spread of highly prevalent and/or emergency diseases that require new treatments (cardiovascular, oncological, degenerative, infectious and genetic) thanks to advanced bio-nanotechnologies for the development of vaccines and innovative adjuvants, medical devices, active ingredients and drugs of a chemical, biological and biotechnological nature, also with a view to industrial reshoring and strengthening of national and European strategic autonomy; • Product innovation and personalized medicine, through projects aimed at developing and producing medical devices and diagnostic tests, drugs based on biological macromolecules and chemical compounds and related delivery systems, cell therapies for immunotherapy and medicine regenerative, aimed at making new research, diagnosis and treatment approaches possible (including precision medicine platforms for decentralized and international clinical studies), with the aim of strengthening the healthcare system in Italy and Europe; • Innovation in production processes through projects of high sustainability and digitalisation (e.g. smart manufacturing, Industry 4.0, robotics, drug screening and repurposing) which lead to an increase in production capacity, added value and competitiveness, reduction of R&D and production costs and times with the aim of strengthening national and European strategic autonomy;• Counteracting antimicrobial resistance and the development of resistant bacterial strains, with research and production projects aimed at increasing therapeutic options, improving access to therapy, strengthening the healthcare system in Italy and Europe;• Digital Health, with the development of platforms and Artificial Intelligence for R&D, digital therapeutics, Real World Data analysis for the purposes of prevention and improvement of access and treatment paths in Italy and Europe.
What does it predict
Concessions for participating entities, authorized under the conditions set by the European Commission Communication relating to the criteria for the analysis of compatibility with the internal market of State aid intended to promote the execution of important projects of common European interest (C (2021) 8481 dated 25.11.2021).
